Investigator-initiated clinical trial opens door for more studies at Norton Cancer Institute,

Dan Ishihara, M.D., Ph.D., has secured Institutional Review Board (IRB) approval for Norton Cancer Institute’s first investigator-initiated trial. With., Dan Ishihara, M.D., Ph.D., has secured Institutional Review Board (IRB) approval for Norton Cancer Institute’s first investigator-initiated trial. With., Read More